课题基金 / 基金详情

Complement activation of intestinal epithelial cells

Complement activation of intestinal epithelial cells
肠上皮细胞的补体激活
批准号:
138632-2010
负责人:
Stadnyk, Andrew
金额:
$2.4万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-01-01 至 2011-12-31

项目摘要

项目成果

Stadnyk, Andrew的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The boundary between your tissues and the lumen in your intestines is a thin sheet of cells called epithelial cells. From this interface with the environment epithelial cells must balance being tolerant of food and some bacteria yet respond with inflammation to other pathogenic bacteria. We think that one way the epithelial cells know to respond to pathogenic bacteria is because another natural defence system becomes activated directly by the bacteria. This defence system is called complement and is intended to make bacteria more easily killed by white blood cells and directly kills bacteria by forming pores on their surface. Complement activation requires a number of proteins be split. We have discovered that epithelial cells have the receptors for these split complement proteins but we do not know what happens to the cells as a result of binding the split proteins. This grant will explore the idea that the split complement proteins cause the epithelial cells to initiate inflammation. This includes recruiting white blood cells from the blood into the gut tissues. Epithelial cells have other molecules on their surface to protect them from the pores that complement assembles. We expect that binding the split complement proteins will result in epithelial cells making more of these protective molecules, to minimize damage by complement on the gut itself. These ideas will be tested using epithelial cells in petri dishes but our findings will then be validated in mice. Mice are chosen because they can be made deficient in complement proteins. The significance is that failures in the communication between epithelial cells and complement may compromise the host response to pathogenic bacteria, possibly causing or worsening disease in man and animals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of complement in epithelial cell interactions with the gut microbiome
  • 批准号:
    RGPIN-2015-04923
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.19万
  • 财政年份:
    2021
  • 负责人:
    Stadnyk, Andrew
  • 依托单位:
The role of complement in epithelial cell interactions with the gut microbiome
  • 批准号:
    RGPIN-2015-04923
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.19万
  • 财政年份:
    2020
  • 负责人:
    Stadnyk, Andrew
  • 依托单位:
The role of complement in epithelial cell interactions with the gut microbiome
  • 批准号:
    RGPIN-2015-04923
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.19万
  • 财政年份:
    2019
  • 负责人:
    Stadnyk, Andrew
  • 依托单位:
Mechanisms of action studies of WBI-4002, a novel drug candidate promoting epithelial integrity
  • 批准号:
    543615-2019
  • 项目类别:
    Engage Grants Program
  • 资助金额:
    $1.82万
  • 财政年份:
    2019
  • 负责人:
    Stadnyk, Andrew
  • 依托单位:
国内基金
海外基金
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
  • 批准号:
    82371103
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    阮静
  • 依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
  • 批准号:
    82371799
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    杨程德
  • 依托单位:
脊髓电刺激活化Na(V)1.1阳性GABA神经元持续缓解癌痛
  • 批准号:
    82371223
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    闻大翔
  • 依托单位:
利用CRISPR内源性激活Atoh1转录促进前庭毛细胞再生和功能重建
  • 批准号:
    82371145
  • 项目类别:
    面上项目
  • 资助金额:
    46.00万元
  • 批准年份:
    2023
  • 负责人:
    陶永
  • 依托单位: